2024 Q2 Form 10-Q Financial Statement

#000008553524000010 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $174.1M $148.9M $170.4M
YoY Change 20.86% -12.61% 4.95%
Cost Of Revenue $25.76M $23.20M $27.01M
YoY Change 4.52% -14.1% 8.64%
Gross Profit $112.7M $87.02M $97.17M
YoY Change -5.63% -10.45% 8.41%
Gross Profit Margin 64.72% 58.44% 57.03%
Selling, General & Admin $10.51M $11.41M $11.00M
YoY Change 15.59% 3.75% 23.17%
% of Gross Profit 9.33% 13.11% 11.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.75M $38.77M $46.33M
YoY Change -6.94% -16.32% -3.46%
% of Gross Profit 31.72% 44.55% 47.68%
Operating Expenses $46.26M $50.18M $57.33M
YoY Change -2.62% -12.47% 0.72%
Operating Profit $102.1M $75.53M $86.06M
YoY Change 41.99% -12.24% 6.8%
Interest Expense -$1.772M -$1.183M -$6.113M
YoY Change -71.72% -80.65% -985.94%
% of Operating Profit -1.74% -1.57% -7.1%
Other Income/Expense, Net
YoY Change
Pretax Income $100.3M $74.34M $79.94M
YoY Change 52.85% -7.01% -1.63%
Income Tax $18.99M $27.03M $15.87M
% Of Pretax Income 18.93% 36.36% 19.85%
Net Earnings $81.21M $47.17M $63.88M
YoY Change 27.99% -26.16% -2.74%
Net Earnings / Revenue 46.65% 31.68% 37.49%
Basic Earnings Per Share $1.23 $0.72 $0.97
Diluted Earnings Per Share $1.23 $0.72 $0.97
COMMON SHARES
Basic Shares Outstanding 65.73M shares 65.69M 65.64M
Diluted Shares Outstanding 65.77M shares 65.74M shares 65.71M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.23M $138.0M $126.8M
YoY Change -30.07% 8.78% -30.97%
Cash & Equivalents $74.23M $138.0M $126.8M
Short-Term Investments
Other Short-Term Assets $2.387M $1.815M $2.091M
YoY Change 0.51% -13.2% -75.5%
Inventory $10.90M $11.42M $11.60M
Prepaid Expenses
Receivables $40.34M $38.76M $46.93M
Other Receivables $5.637M $3.109M $1.724M
Total Short-Term Assets $133.5M $193.0M $189.2M
YoY Change -19.21% 2.05% -26.86%
LONG-TERM ASSETS
Property, Plant & Equipment $3.054B $3.038B $3.191B
YoY Change -3.22% -4.79% 31.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.172M
YoY Change -49.04%
Other Assets $81.54M $81.77M $110.5M
YoY Change -31.11% -25.99% 13.29%
Total Long-Term Assets $3.136B $3.120B $3.302B
YoY Change -4.24% -5.5% 30.45%
TOTAL ASSETS
Total Short-Term Assets $133.5M $193.0M $189.2M
Total Long-Term Assets $3.136B $3.120B $3.302B
Total Assets $3.269B $3.313B $3.491B
YoY Change -4.96% -5.09% 25.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.23M $11.60M $7.852M
YoY Change 54.67% 47.72% 25.29%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $50.00M
YoY Change
Total Short-Term Liabilities $122.4M $77.15M $55.00M
YoY Change 94.05% 40.27% 11.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $146.2M $496.8M
YoY Change -100.0% -70.58%
Other Long-Term Liabilities $7.094M $7.676M $7.501M
YoY Change -21.9% 2.33% 16.57%
Total Long-Term Liabilities $7.094M $153.9M $504.3M
YoY Change -98.25% -69.49% 7737.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $122.4M $77.15M $55.00M
Total Long-Term Liabilities $7.094M $153.9M $504.3M
Total Liabilities $287.8M $389.9M $696.1M
YoY Change -53.29% -43.98% 384.28%
SHAREHOLDERS EQUITY
Retained Earnings $742.3M $687.4M $566.5M
YoY Change 22.62% 21.33% 33.43%
Common Stock $656.0K $656.0K $656.0K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.969B $2.911B $2.783B
YoY Change
Total Liabilities & Shareholders Equity $3.269B $3.313B $3.491B
YoY Change -4.96% -5.09% 25.13%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $81.21M $47.17M $63.88M
YoY Change 27.99% -26.16% -2.74%
Depreciation, Depletion And Amortization $35.75M $38.77M $46.33M
YoY Change -6.94% -16.32% -3.46%
Cash From Operating Activities $113.5M $138.3M $108.7M
YoY Change 5.18% 27.27% 7.44%
INVESTING ACTIVITIES
Capital Expenditures $51.15M $1.104M $0.00
YoY Change 1815.81% -100.0%
Acquisitions
YoY Change
Other Investing Activities $220.0K $305.0K $197.0K
YoY Change 378.26% 54.82% 1690.91%
Cash From Investing Activities -$50.93M $23.59M -$197.0K
YoY Change 1841.01% -12075.13% -99.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $100.0M $75.00M
YoY Change 33.33%
Cash From Financing Activities -126.3M -$128.1M -100.2M
YoY Change 0.27% 27.8% 332.65%
NET CHANGE
Cash From Operating Activities 113.5M $138.3M 108.7M
Cash From Investing Activities -50.93M $23.59M -197.0K
Cash From Financing Activities -126.3M -$128.1M -100.2M
Net Change In Cash -63.72M $33.78M 8.230M
YoY Change 208.43% 310.49% -79.5%
FREE CASH FLOW
Cash From Operating Activities $113.5M $138.3M $108.7M
Capital Expenditures $51.15M $1.104M $0.00
Free Cash Flow $62.36M $137.2M $108.7M
YoY Change -40.75% 26.25% -21.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
21751000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
25020000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11412000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11000000 usd
CY2024Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
1449000 usd
CY2023Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
1989000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38765000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46328000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
73377000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
84337000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
75525000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
86055000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
447000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
799000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2977000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2263000 usd
CY2024Q1 rgld Interest And Other Expense
InterestAndOtherExpense
4607000 usd
CY2023Q1 rgld Interest And Other Expense
InterestAndOtherExpense
9175000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74342000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79942000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27033000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15871000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
47309000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
64071000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
143000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
196000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
47166000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
63875000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65637428 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65594977 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65740260 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65709095 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.375
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2900641000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1982000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
255000 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
26311000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2923366000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2753469000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2239000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
203000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
64071000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24644000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2794932000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
47309000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
64071000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38765000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46328000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2988000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2636000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
447000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
799000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
648000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1092000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-222000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-214000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10127000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2471000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1629000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1056000 usd
CY2024Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
433000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1342000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10763000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
914000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
158000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1166000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6465000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7840000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25000000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1652000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2168000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
138284000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
108655000 usd
CY2024Q1 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
1104000 usd
CY2023Q1 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
0 usd
CY2024Q1 rgld Proceeds From Debt Facility
ProceedsFromDebtFacility
25000000 usd
CY2023Q1 rgld Proceeds From Debt Facility
ProceedsFromDebtFacility
0 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
305000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
197000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23591000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-197000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
75000000 usd
CY2024Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-1369000 usd
CY2023Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-397000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
26292000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24629000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-431000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-202000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-128092000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-100228000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33783000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8230000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104167000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118586000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137950000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126816000 usd
CY2024Q1 us-gaap Mineral Properties Gross
MineralPropertiesGross
4875799000 usd
CY2024Q1 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
1837304000 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
3038495000 usd
CY2023Q4 us-gaap Mineral Properties Gross
MineralPropertiesGross
4874194000 usd
CY2023Q4 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
1798620000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
3075574000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
150000000 usd
CY2024Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3813000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
146187000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
250000000 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4033000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
245967000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
150000000 usd
CY2024Q1 rgld Cost Support Agreement Delivery Period After Initial Transfer
CostSupportAgreementDeliveryPeriodAfterInitialTransfer
P30D
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
148902000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
148902000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2988000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2636000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
159690 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
138890 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
47166000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
63875000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65637428 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65594977 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
102832 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
114118 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65740260 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65709095 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27033000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15871000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.364
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.199
CY2024Q1 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
13000000 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
3038495000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
3075574000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
148902000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
21751000 usd
CY2024Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
1449000 usd
CY2024Q1 us-gaap Depletion
Depletion
38683000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
87019000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
25020000 usd
CY2023Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
1989000 usd
CY2023Q1 us-gaap Depletion
Depletion
46214000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
97169000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
87019000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
97169000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11412000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
82000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
114000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
75525000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
86055000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
447000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
799000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2977000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2263000 usd
CY2024Q1 rgld Interest And Other Expense
InterestAndOtherExpense
4607000 usd
CY2023Q1 rgld Interest And Other Expense
InterestAndOtherExpense
9175000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74342000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79942000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
148902000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
170392000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000085535-24-000010-index-headers.html Edgar Link pending
0000085535-24-000010-index.html Edgar Link pending
0000085535-24-000010.txt Edgar Link pending
0000085535-24-000010-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgld-20240331.htm Edgar Link pending
rgld-20240331.xsd Edgar Link pending
rgld-20240331xex311.htm Edgar Link pending
rgld-20240331xex312.htm Edgar Link pending
rgld-20240331xex321.htm Edgar Link pending
rgld-20240331xex322.htm Edgar Link pending
Show.js Edgar Link pending
rgld-20240331_def.xml Edgar Link unprocessable
rgld-20240331_cal.xml Edgar Link unprocessable
rgld-20240331_lab.xml Edgar Link unprocessable
rgld-20240331_pre.xml Edgar Link unprocessable
rgld-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable